Cervomed Inc CRVO

$2.29 +0.02 (0.88%)

Valuation

Market cap
34,320,000
Revenue TTM
$4,010,000
Net income TTM
$-26,970,000
PE ratio
0.00
Forward PE
—
Profit margin
-672.57%
Debt to equity
0.00

Trading

Volume
497,100
Avg volume
293,268
Day's range
$2.13 – $2.41
Shares out
15,119,000
Stochastic %K
12%
Beta
-0.75
Analysts
Strong Sell
Price target
$18.00

Price

Company profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease...

Show more

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 744 4400
Website
https://www.cervomed.com
Address
20 Park Plaza, Suite 424, Boston, United States

Latest news

Stocktwits

gboyce1220 Oct 14, 9:19 PM
$CRVO Many ppl suffer across the world(3.9M) with early onset dementia in many forms. They would do anything to slow the progression and enjoy more meaningful and productive time with family and their lives. $CRVO only needs the drug to slow the progression and that’s a plentiful market to make $. If it improves speech & motor that’s just xtra gravy.
0 replies
janed102 Oct 14, 7:00 PM
$CRVO sinking ship
1 replies
walker7782 Oct 14, 5:33 PM
$CRVO Couldn’t say no to those prices, zero liquidity means gut checking drops to hunt stop losses are easy. Added at 2.17.
0 replies
Disinformation_Consumer Oct 14, 5:32 PM
$CRVO theyre probably gonna go bankrupt at this rate.
0 replies
Ghostofgreg1 Oct 14, 4:41 PM
$CRVO There really are no words for the true longs that have been here far too long. Cant even cost avg down enough to make me feel hopeful anymore at this point. 60 or so days left until they really are in trouble. Need a miracle. Cost average by the way is way over teen levels Need slownsteady to pump us up
3 replies
Houseofsweeps Oct 14, 3:06 PM
$CRVO hope yall loaded on that dip back down to 52 week low. 🤞 could get fun again
0 replies
walker7782 Oct 14, 1:53 PM
$CRVO Needs to break out of this channel here above 2.33 to start an oversold recovery or a retest of 52 week low is on deck...
0 replies
walker7782 Oct 14, 11:25 AM
$CRVO Done buying for now, $2.40 avg. but didn’t reload full position after last swing from 2.60 - high $3.20’s. Volume looks to be drying up today after institutional repositioning.
0 replies